Center for Bioethics at University of Minnesota, USA.
J Law Med Ethics. 2009 Winter;37(4):685-7. doi: 10.1111/j.1748-720X.2009.00440.x.
This commentary asks what we can learn from our oversight of controversial science and how can we do better in the future? After briefly examining the history of gene transfer research oversight, some observations are offered for the oversight of nanobiotechnology and other emerging areas of science.
本评论探讨了我们从对有争议的科学的忽视中可以吸取什么教训，以及我们如何在未来做得更好？在简要回顾了基因转移研究监督的历史之后，对纳米生物技术和其他新兴科学领域的监督提出了一些看法。
